SFX by Ex Libris Inc.

Title:	Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells
Source:	Nature Immunology [1529-2908] Phan, Ryan yr:2007

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Dalla-Favera, K. "A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma." Cancer cell 12.3 (2007): 280-92.
description	2.	Jabara, Haifa H H. "B-cell receptor cross-linking delays activation-induced cytidine deaminase induction and inhibits class-switch recombination to IgE." The journal of allergy and clinical immunology 121.1 (2007): 191-196.
description	3.	Bonnefoy, J Y Y. "Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L." The European respiratory journal. Supplement 22 (1996): 63-66.
description	4.	Loh, R K K. "Role of protein tyrosine kinases and phosphatases in isotype switching: crosslinking CD45 to CD40 inhibits IgE isotype switching in human B cells." Immunology letters 45.1-2 (1995): 99-106.
description	5.	Katada, Y. "B cell-B cell interaction through intercellular adhesion molecule-1 and lymphocyte functional antigen-1 regulates immunoglobulin E synthesis by B cells stimulated with interleukin-4 and anti-CD40 antibody." European journal of immunology 26.1 (1995): 192-200.
description	6.	Jabara, Haifa H H. "Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells." The journal of allergy and clinical immunology 115.4 (2005): 856-63.
description	7.	Kitayama D, Sakamoto A, Arima M, Hatano M, Miyazak, D. "A role for Bcl6 in sequential class switch recombination to IgE in B cells stimulated with IL-4 and IL-21." Molecular immunology 45.5 (2007): 1337-45.
description	8.	Sjö, E. "Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups." European journal of haematology 79.6 (2008): 501-7.
description	9.	Lossos, Izidore S S. "The Endless Complexity of Lymphocyte Differentiation and Lymphomagenesis: IRF-4 Downregulates BCL6 Expression." Cancer cell 12.3 (2007): 189-91.
description	10.	Ross, C.W. W. "Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis." Clinical cancer research 13.16 (2007): 4777-4785.
description	11.	Dalla-Favera, R. "Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma." The Journal of experimental medicine 203.2 (2006): 311-7.
description	12.	Geha, N. "Sequential switching from mu to epsilon via gamma 4 in human B cells stimulated with IL-4 and hydrocortisone." The journal of immunology 151.9 (1993): 4528-33.
description	13.	Roper, R L L. "Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE." The journal of immunology 154.1 (1994): 162-70.
description	14.	Challa, A. "Epitope-dependent synergism and antagonism between CD40 antibodies and soluble CD40 ligand for the regulation of CD23 expression and IgE synthesis in human B cells." Allergy 54.6 (1999): 576-83.
description	15.	Kimata, H. "Differential effect of vasoactive intestinal peptide, somatostatin, and substance P on human IgE and IgG subclass production." Cellular immunology 144.2 (1992): 429-42.
description	16.	Bacharier, L B B. "Molecular mechanisms of immunoglobulin E regulation." International archives of allergy and immunology 115.4 (1998): 257-69.
description	17.	Bonnefoy, J Y Y. "A new pair of surface molecules involved in human IgE regulation." Immunology today (1992): 1-2.
description	18.	Kridel, R. "Pathogenesis of follicular lymphoma." The Journal of clinical investigation 122.10 (2012): 3424-3431.
description	19.	Brass, A L L. "Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers." The EMBO journal 18.4 (1999): 977-91.
description	20.	Touzeau, C. "High grade non-Hodgkin's lymphoma with tandem t(14;18) and c-MYC rearrangement is a pathological lymphoma entity with aggressive clinical presentation and very poor prognosis." Blood 108.11 (2006): 579-579.